top of page
Qubigen to Attend BIO International Convention 2026 in San Diego
Qubigen is excited to announce our participation in the upcoming BIO International Convention 2026 in San Diego, taking place from June 22-26, 2026. A Global Stage for Biotechnology Innovation The BIO International Convention is the world’s biggest and most comprehensive biotechnology event, representing the full breadth of the global biotech ecosystem, bringing together over 20,000 industry leaders from biotech, pharmaceuticals, academia, and investment communities. The conv
4 hours ago2 min read
Tailored AI vs Generalist Models: A Federated Approach to Blood-Brain-Barrier Permeability
Qubigen’s recent study on tailored federated AI for blood-brain-barrier permeability prediction has now been featured by Diagnostics World News in an article exploring why specialized AI systems are outperforming generic foundation models in life sciences. One Size Fits Few: Where Tailored AI Tools Outpace Generic Options The feature highlights Qubigen’s findings that federated, client-adapted AI Engines can dramatically outperform generalist models when applied to real-world
Apr 305 min read
Qubigen Launches Collaborative Federated AI Antiviral Drug Design Project
Qubigen is pleased to announce the launch of a new collaborative Federated AI drug design project focused on the development of novel antiviral small molecules for emerging infectious diseases. This initiative reflects Qubigen’s commitment to shortening development timelines and advancing next-generation drug discovery through secure, collaborative AI technologies. Enabling Secure Multi-Party Drug Design with Qubigen’s FedAIDD This multi-party initiative consists of nonprofit
Apr 293 min read
bottom of page